Original Article
Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter Study
Redefiniendo la retirada de omalizumab en pacientes con urticaria crónica espontánea: el valor de la optimización y de los biomarcadores de recurrencia
J. Ceravallsa,
, A.M. Giménez-Arnaub, V. Expósito-Serranoc, N. Fernández Chicoc, A. Lara Moyac, I. Bielsad, P. Ribóe, B. Mascaró-Herezae, M. Bonfill-Ortíf, J. Spertinog, E. Serrag, C. Baliu-Piquéh, G. Melé-Ninota
a Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo QuirónSalud, Barcelona, Catalonia, Spain
b Department of Dermatology, Hospital de Mar Research Institute, Universitat Pompeu Fabra, Barcelona, Catalonia, Spain
c Department of Dermatology, Consorci Sanitari Parc Taulí, Sabadell, Catalonia, Spain
d Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Catalonia, Spain
e Department of Allergology, Hospital Clínic, Universitat de Barcelona, Catalonia, Spain
f Department of Dermatology, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Catalonia, Spain
g Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain
h Department of Dermatology, Hospital d’Igualada-Consorci Sanitari de l’Anoia, Barcelona, Catalonia, Spain
Leído
3216
Vecesse ha leído el artículo
744
Total PDF
2472
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 9 | 149 | 43 | 192 |
| 2025 8 | 580 | 136 | 716 |
| 2025 7 | 317 | 81 | 398 |
| 2025 6 | 426 | 230 | 656 |
| 2025 5 | 468 | 79 | 547 |
| 2025 4 | 324 | 81 | 405 |
| 2025 3 | 208 | 94 | 302 |
